Edge Therapeutics, Inc. 4
4 · Edge Therapeutics, Inc. · Filed Nov 2, 2016
Insider Transaction Report
Form 4
BRENNAN DANIEL
Chief Operating Officer
Transactions
- Award
Stock Option (right To Purchase)
2016-11-01$10.09/sh+150,000$1,513,500→ 150,000 totalExercise: $10.09Exp: 2026-10-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 150,000 shares of Common Stock, will become exercisable on October 17, 2017, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.